Monotherapy Versus Placebo Over 7 Days-Non-Nucleoside Reverse Transcriptase Inhibitor-Experienced HIV1 Infected Adults

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2004
To investigate safety, tolerability and antiviral activity in Non-nucleoside reverse transcriptase inhibitor (NNRTI)-experienced HIV-1 infected patients
Epistemonikos ID: 75e2b51cb155f29b5d1d02aa697a93d3ad826fe1
First added on: Dec 01, 2021